_id
6917202b3c536f8df2316871
Ticker
TNPH
Name
Tian'an Pharmaceutical Co Ltd
Exchange
PINK
Address
International Trade Centre, Xi'an, China
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
-
Description
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels. Its products also include Tianan Pain Relief Capsule, a Chinese medicine preparation, which is under development to cure pain in joints, headache, pain from muscle injury, cancer, and gynecological disorders, as well as general pain. Tian' An Pharmaceutical sells its products to independent distributors, who sell products to pharmacies and drugstores, and hospitals. The company was founded in 2003 and is based in Xi'an, China.
Last Close
0.0033
Volume
-
Current Price
0.0033
Change
0
Last Updated
2026-01-07T13:18:32.154Z
Ipo Date
-
Market Cap
2000000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-12-31
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
6156
Operating Income
-6156
Interest Expense
-
Pretax Income
10844
Net Income
10580
Eps
0.000013225
Dividends Per Share
-
Shares Outstanding
800000000
Income Tax Expense
-
EBITDA
10844
Operating Margin
-
Total Other Income Expense Net
17000
Cash
143
Short Term Investments
-
Receivables
5566
Inventories
-
Total Current Assets
5709
Property Plant Equipment
-
Total Assets
5709
Payables
-
Short Term Debt
61859
Long Term Debt
-
Total Liabilities
91359
Equity
-85650
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-10207
Cash From Operations
-1970
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
1940
Net Change In Cash
-30
Cf_currency_symbol
-
PE
0
PB
-30.823117338003506
ROE
-12.352597781669585
ROA
185.32142231564197
FCF
-1970
Fcf Percent
-
Piotroski FScore
1
Health Score
47
Deep Value Investing Score
3.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
5
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
6156
Quarters > 0 > income Statement > operating Income
-6156
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
10844
Quarters > 0 > income Statement > net Income
10580
Quarters > 0 > income Statement > eps
0.000013225
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
800000000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
10844
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
17000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
143
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
5566
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
5709
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
5709
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
61859
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
91359
Quarters > 0 > balance Sheet > equity
-85650
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
10580
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-10207
Quarters > 0 > cash Flow > cash From Operations
-1970
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
1940
Quarters > 0 > cash Flow > net Change In Cash
-30
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.000013225
Quarters > 0 > ratios > PB
-30.823117338003506
Quarters > 0 > ratios > ROE
-12.352597781669585
Quarters > 0 > ratios > ROA
185.32142231564197
Quarters > 0 > ratios > FCF
-1970
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
47
Quarters > 1 > quarter
2024-09-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
3179
Quarters > 1 > income Statement > operating Income
-3179
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3179
Quarters > 1 > income Statement > net Income
-3179
Quarters > 1 > income Statement > eps
-0.00000397375
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
800000000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3179
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
173
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1326
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1499
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
1499
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
54918
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
95418
Quarters > 1 > balance Sheet > equity
-93919
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-3179
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
2061
Quarters > 1 > cash Flow > cash From Operations
-1118
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1073
Quarters > 1 > cash Flow > net Change In Cash
-45
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.00000397375
Quarters > 1 > ratios > PB
-28.10932825093964
Quarters > 1 > ratios > ROE
3.384831610217315
Quarters > 1 > ratios > ROA
-212.07471647765175
Quarters > 1 > ratios > FCF
-1118
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
2985
Quarters > 2 > income Statement > operating Income
-2980
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-2985
Quarters > 2 > income Statement > net Income
-2985
Quarters > 2 > income Statement > eps
-0.00000373125
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
800000000
Quarters > 2 > income Statement > income Tax Expense
-2985
Quarters > 2 > income Statement > EBITDA
-2985
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-5
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
218
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1920
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2138
Quarters > 2 > balance Sheet > property Plant Equipment
1550
Quarters > 2 > balance Sheet > total Assets
3688
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
53846
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
94396
Quarters > 2 > balance Sheet > equity
-90708
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-2985
Quarters > 2 > cash Flow > depreciation
-5
Quarters > 2 > cash Flow > change In Working Capital
2940
Quarters > 2 > cash Flow > cash From Operations
-45
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-45
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.00000373125
Quarters > 2 > ratios > PB
-29.104378886096043
Quarters > 2 > ratios > ROE
3.2907792035983596
Quarters > 2 > ratios > ROA
-80.93817787418655
Quarters > 2 > ratios > FCF
-45
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
26
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
6092
Quarters > 3 > income Statement > operating Income
-6090
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-6092
Quarters > 3 > income Statement > net Income
-5828
Quarters > 3 > income Statement > eps
-0.000007285
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
800000000
Quarters > 3 > income Statement > income Tax Expense
-264
Quarters > 3 > income Statement > EBITDA
-6090
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-2
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
263
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
3360
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3623
Quarters > 3 > balance Sheet > property Plant Equipment
1550
Quarters > 3 > balance Sheet > total Assets
5173
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
53486
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
92896
Quarters > 3 > balance Sheet > equity
-87723
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-5828
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
3440
Quarters > 3 > cash Flow > cash From Operations
-45
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-2314
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.000007285
Quarters > 3 > ratios > PB
-30.0947300023939
Quarters > 3 > ratios > ROE
6.643639638407259
Quarters > 3 > ratios > ROA
-112.6618983181906
Quarters > 3 > ratios > FCF
-45
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
29
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
18412
Annuals > 0 > income Statement > operating Income
-18412
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-1412
Annuals > 0 > income Statement > net Income
-1412
Annuals > 0 > income Statement > eps
-0.000001765
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
800000000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1412
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
17000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
143
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
5566
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5709
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
5709
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
61859
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
91359
Annuals > 0 > balance Sheet > equity
-85650
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-1412
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-1766
Annuals > 0 > cash Flow > cash From Operations
-3178
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
3013
Annuals > 0 > cash Flow > net Change In Cash
-2434
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.000001765
Annuals > 0 > ratios > PB
-30.823117338003506
Annuals > 0 > ratios > ROE
1.6485697606538237
Annuals > 0 > ratios > ROA
-24.732877912068663
Annuals > 0 > ratios > FCF
-3178
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
25
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
142840
Annuals > 1 > income Statement > cost Of Revenue
75252
Annuals > 1 > income Statement > gross Profit
67588
Annuals > 1 > income Statement > operating Expenses
78239
Annuals > 1 > income Statement > operating Income
-10651
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-10306
Annuals > 1 > income Statement > net Income
-16027
Annuals > 1 > income Statement > eps
-0.00004603895940438415
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
348118207
Annuals > 1 > income Statement > income Tax Expense
630
Annuals > 1 > income Statement > EBITDA
-10150
Annuals > 1 > income Statement > operating Margin
-7.4565947913749655
Annuals > 1 > income Statement > total Other Income Expense Net
345
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
2577
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
337496
Annuals > 1 > balance Sheet > inventories
17951
Annuals > 1 > balance Sheet > total Current Assets
358024
Annuals > 1 > balance Sheet > property Plant Equipment
1567
Annuals > 1 > balance Sheet > total Assets
359591
Annuals > 1 > balance Sheet > payables
368053
Annuals > 1 > balance Sheet > short Term Debt
56947
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
425000
Annuals > 1 > balance Sheet > equity
-70504
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-16027
Annuals > 1 > cash Flow > depreciation
153
Annuals > 1 > cash Flow > change In Working Capital
14472
Annuals > 1 > cash Flow > cash From Operations
-13024
Annuals > 1 > cash Flow > capital Expenditures
4
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
13450
Annuals > 1 > cash Flow > net Change In Cash
426
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-0.00004603895940438415
Annuals > 1 > ratios > PB
-16.293970315159424
Annuals > 1 > ratios > ROE
22.732043571995916
Annuals > 1 > ratios > ROA
-4.457008100870155
Annuals > 1 > ratios > FCF
-13028
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.09120694483338
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
7500
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
7500
Annuals > 2 > income Statement > operating Expenses
40949
Annuals > 2 > income Statement > operating Income
-33450
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-20449
Annuals > 2 > income Statement > net Income
-20449
Annuals > 2 > income Statement > eps
-0.00031049190548255307
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
65860010
Annuals > 2 > income Statement > income Tax Expense
-228485
Annuals > 2 > income Statement > EBITDA
208036
Annuals > 2 > income Statement > operating Margin
-446
Annuals > 2 > income Statement > total Other Income Expense Net
13000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
2151
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
5270
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
7421
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
7421
Annuals > 2 > balance Sheet > payables
26497
Annuals > 2 > balance Sheet > short Term Debt
181996
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
208493
Annuals > 2 > balance Sheet > equity
-201072
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-20449
Annuals > 2 > cash Flow > depreciation
228485
Annuals > 2 > cash Flow > change In Working Capital
6411
Annuals > 2 > cash Flow > cash From Operations
-14038
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
6428
Annuals > 2 > cash Flow > net Change In Cash
-105029
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-0.00031049190548255307
Annuals > 2 > ratios > PB
-1.0808965594413942
Annuals > 2 > ratios > ROE
10.169988859711944
Annuals > 2 > ratios > ROA
-275.55585500606384
Annuals > 2 > ratios > FCF
-14038
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.8717333333333332
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
31395
Annuals > 3 > income Statement > operating Income
-31399
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-31395
Annuals > 3 > income Statement > net Income
-31395
Annuals > 3 > income Statement > eps
-0.0006279626706745333
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
49995010
Annuals > 3 > income Statement > income Tax Expense
-236557
Annuals > 3 > income Statement > EBITDA
-31399
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
4
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
107180
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
289253
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
396433
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
396433
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
175568
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
522346
Annuals > 3 > balance Sheet > equity
-139350
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-31395
Annuals > 3 > cash Flow > depreciation
236558
Annuals > 3 > cash Flow > change In Working Capital
5176
Annuals > 3 > cash Flow > cash From Operations
-26219
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
20980
Annuals > 3 > cash Flow > net Change In Cash
92180
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.0006279626706745333
Annuals > 3 > ratios > PB
-1.1839507212055975
Annuals > 3 > ratios > ROE
22.529601722282024
Annuals > 3 > ratios > ROA
-7.919370990810553
Annuals > 3 > ratios > FCF
-26219
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
38
Valuation > metrics > PE
0.000013225
Valuation > metrics > PB
-30.823117338003506
Valuation > final Score
70
Valuation > verdict
100.0% Undervalued
Profitability > metrics > ROE
-12.352597781669585
Profitability > metrics > ROA
185.32142231564197
Profitability > final Score
45
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.09229053169304385
Liquidity > metrics > Quick Ratio
0.09229053169304385
Liquidity > final Score
15
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
22
Prev Profitabilities > 1
22
Prev Profitabilities > 2
28
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
-12150
Prev Liquidities > 0
11
Prev Liquidities > 1
12
Prev Liquidities > 2
13
Updated At
2026-01-20T22:42:38.228Z
Earnings History > 0 > period
2024-12-31
Earnings History > 0 > report Date
2024-12-31
Earnings History > 0 > date
2024-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-09-30
Earnings History > 1 > report Date
2024-09-30
Earnings History > 1 > date
2024-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-06-30
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-03-31
Earnings History > 3 > report Date
2024-03-31
Earnings History > 3 > date
2024-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-12-31
Earnings History > 4 > report Date
2023-12-31
Earnings History > 4 > date
2023-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-09-30
Earnings History > 5 > report Date
2023-09-30
Earnings History > 5 > date
2023-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.0001
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-06-30
Earnings History > 6 > report Date
2023-06-30
Earnings History > 6 > date
2023-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-03-31
Earnings History > 7 > report Date
2023-03-31
Earnings History > 7 > date
2023-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0001
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-12-31
Earnings History > 8 > report Date
2022-12-31
Earnings History > 8 > date
2022-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-09-30
Earnings History > 9 > report Date
2022-09-30
Earnings History > 9 > date
2022-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-06-30
Earnings History > 10 > report Date
2022-06-30
Earnings History > 10 > date
2022-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0.0001
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-03-31
Earnings History > 11 > report Date
2022-03-31
Earnings History > 11 > date
2022-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.0004
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2021-12-31
Earnings History > 12 > report Date
2021-12-31
Earnings History > 12 > date
2021-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.0001
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-09-30
Earnings History > 13 > report Date
2021-09-30
Earnings History > 13 > date
2021-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.0001
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-06-30
Earnings History > 14 > report Date
2021-06-30
Earnings History > 14 > date
2021-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.0004
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-03-31
Earnings History > 15 > report Date
2021-03-31
Earnings History > 15 > date
2021-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.0001
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2020-12-31
Earnings History > 16 > report Date
2020-12-31
Earnings History > 16 > date
2020-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.0004
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2020-09-30
Earnings History > 17 > report Date
2020-09-30
Earnings History > 17 > date
2020-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.0003
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-06-30
Earnings History > 18 > report Date
2020-06-30
Earnings History > 18 > date
2020-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.0004
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-03-31
Earnings History > 19 > report Date
2020-03-31
Earnings History > 19 > date
2020-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.0006
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2019-12-31
Earnings History > 20 > report Date
2019-12-31
Earnings History > 20 > date
2019-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.0008
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-09-30
Earnings History > 21 > report Date
2019-09-30
Earnings History > 21 > date
2019-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.0006
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-06-30
Earnings History > 22 > report Date
2019-06-30
Earnings History > 22 > date
2019-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.0005
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-03-31
Earnings History > 23 > report Date
2019-03-31
Earnings History > 23 > date
2019-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.0004
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2018-09-30
Earnings History > 24 > report Date
2018-09-30
Earnings History > 24 > date
2018-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-0.0003
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2018-06-30
Earnings History > 25 > report Date
2018-06-30
Earnings History > 25 > date
2018-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
0
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-03-31
Earnings History > 26 > report Date
2018-03-31
Earnings History > 26 > date
2018-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
0
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2017-03-31
Earnings History > 27 > report Date
2017-03-31
Earnings History > 27 > date
2017-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
0
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2008-03-31
Earnings History > 28 > report Date
2008-04-15
Earnings History > 28 > date
2008-03-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
0.04
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0.04
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2007-12-31
Earnings History > 29 > report Date
2007-12-31
Earnings History > 29 > date
2007-12-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
0.0355
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2007-09-30
Earnings History > 30 > report Date
2007-11-13
Earnings History > 30 > date
2007-09-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
0.06
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
0.06
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2007-06-30
Earnings History > 31 > report Date
2007-08-10
Earnings History > 31 > date
2007-06-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
0.07
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
0.07
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2007-03-31
Earnings History > 32 > report Date
2007-05-15
Earnings History > 32 > date
2007-03-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
-
Earnings History > 32 > eps Actual
0.06
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
0.06
Earnings History > 32 > surprise Percent
-
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels. Its products also include Tianan Pain Relief Capsule, a Chinese medicine preparation, which is under development to cure pain in joints, headache, pain from muscle injury, cancer, and gynecological disorders, as well as general pain. Tian' An Pharmaceutical sells its products to independent distributors, who sell products to pharmacies and drugstores, and hospitals. The company was founded in 2003 and is based in Xi'an, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Tian'an Pharmaceutical Co Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-12-31
EPS Actual
0
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.